article mda quest magazine government funding neuromuscular disease research government funding nmd research largely spared continuing resolution congressional funding bill spared government programs sponsor neuromuscular research protect upcoming deep sequester cuts article highlights government programs fund neuromuscular disease research fared well recent continuing resolution passed congress march continuing resolution funds government end september neuromuscular disease research sponsored several government agencies including national institutes health food drug administration centers disease control prevention department defense continuing resolution avert pending cuts caused sequester mda advocacy program continue work ensure congressional appropriators understand importance life altering work decisions made funding fiscal year quest staff march pm news generally favorable many important government funded neuromuscular disease research projects wake congress recent passage continuing resolution funding government end september government operations except funded full year appropriations bills maintained essentially level fiscal year fy government fiscal year begins oct ends sept following year neuromuscular disease research projects spread across several governmental agencies including national institutes health nih food drug administration fda centers disease control prevention cdc department defense dod nih fda agencies received slight funding increases continuing resolution bill agencies fund basic clinical translational research neuromuscular disease well oversee approval new drugs biologic products medical devices cdc funding bill maintained last year funding level cdc agency implements muscular dystrophy program cdc national center birth defects developmental disability ncbdd established md care national als registry cdc agency toxic substances disease registries atsdr established als registry dod one full year appropriations bills included continuing resolution funding dod congress directed fy funding amyotrophic lateral sclerosis als research slightly increased funding maintained current level duchenne muscular dystrophy dmd fiscal year dod funding als research million increase million fy dmd funding held steady million mda pleased congressional funding bill continue allow progression vital research critical therapy development said annie kennedy mda senior vice president advocacy halting discovery momentum promising time reducing federal scientific funding would worst case scenario since potential still exists continuing work ensure congressional appropriators understand importance life altering work funded nih fda cdc dod decisions made funding fiscal year kennedy noted continuing resolution avert pending deep federal budget cuts known sequester although give leeway agencies deciding make cuts mda working representatives ed markey mass david mckinley r va coalition national patient advocacy organizations convince congress give full funding medical research next fiscal year raise voice urged kennedy tell congress provide full funding vitally important research